Skip to content
10-K

Annual Report

VIELA BIO, INC.

0001564590-21-009902

← back to feed
Filed
Mar 1, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 1, 2021 54.95M sh
Capex FY 2020 · Dec 31, 2020 $926K
Capex FY 2020 · Dec 31, 2019 $1.1M
Capex FY 2020 · Dec 31, 2018 $491K
Operating Cash Flow FY 2020 · Dec 31, 2020 −$106.11M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$105.05M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$29.53M
Cash And Equivalents FY 2020 · Dec 31, 2020 $130.07M
Cash And Equivalents FY 2020 · Dec 31, 2019 $200.85M
Stockholders Equity FY 2020 · Dec 31, 2020 $375.83M
Stockholders Equity FY 2020 · Dec 31, 2019 $354.51M
Stockholders Equity FY 2020 · Dec 31, 2018 −$188.39M
Current Liabilities FY 2020 · Dec 31, 2020 $46.05M
Current Liabilities FY 2020 · Dec 31, 2019 $29.54M
Total Liabilities FY 2020 · Dec 31, 2020 $47.43M
Total Liabilities FY 2020 · Dec 31, 2019 $29.54M
Current Assets FY 2020 · Dec 31, 2020 $389.3M
Current Assets FY 2020 · Dec 31, 2019 $351.04M
Total Assets FY 2020 · Dec 31, 2020 $423.26M
Total Assets FY 2020 · Dec 31, 2019 $384.05M
Sga Expense FY 2020 · Dec 31, 2020 $60.19M
Sga Expense FY 2020 · Dec 31, 2019 $35.05M
Sga Expense FY 2020 · Dec 31, 2018 $6.57M
Net Income FY 2020 · Dec 31, 2020 −$150.67M
Net Income FY 2020 · Dec 31, 2019 −$86.43M
Net Income FY 2020 · Dec 31, 2018 −$190.27M
Operating Income FY 2020 · Dec 31, 2020 −$153.88M
Operating Income FY 2020 · Dec 31, 2019 −$89.69M
Operating Income FY 2020 · Dec 31, 2018 −$192.31M
Revenue FY 2020 · Dec 31, 2020 $11.65M
Revenue FY 2020 · Dec 31, 2019 $50M